IDEXX Laboratories Announces Second Quarter Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
IDEXX Laboratories (IDXX) PT Raised to $785 at Jefferies
August 5, 2025 6:21 AM EDTJefferies analyst Keith Devas raised the price target on IDEXX Laboratories (NASDAQ: IDXX) to $785.00 (from $625.00) while maintaining a Buy rating.
The analyst comments "Strong 2Q results (sales +10.6%, EBITDA +14%) and higher guidance confirms the innovation playbook is working. Management's decision to pull-forward spend in... More
